DK1951274T3 - Parapoxvirusser i kombination med klasssiske cytotoksiske kemoterapeutiske midler som biokemoterapi til behandling af cancer - Google Patents

Parapoxvirusser i kombination med klasssiske cytotoksiske kemoterapeutiske midler som biokemoterapi til behandling af cancer

Info

Publication number
DK1951274T3
DK1951274T3 DK06806214.0T DK06806214T DK1951274T3 DK 1951274 T3 DK1951274 T3 DK 1951274T3 DK 06806214 T DK06806214 T DK 06806214T DK 1951274 T3 DK1951274 T3 DK 1951274T3
Authority
DK
Denmark
Prior art keywords
parapoxviruses
biochemotherapy
cancer
treatment
combination
Prior art date
Application number
DK06806214.0T
Other languages
English (en)
Inventor
Olaf Weber
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37654955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1951274(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Application granted granted Critical
Publication of DK1951274T3 publication Critical patent/DK1951274T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/768Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24211Parapoxvirus, e.g. Orf virus
    • C12N2710/24232Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
DK06806214.0T 2005-11-24 2006-10-12 Parapoxvirusser i kombination med klasssiske cytotoksiske kemoterapeutiske midler som biokemoterapi til behandling af cancer DK1951274T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025600 2005-11-24
PCT/EP2006/009855 WO2007059821A1 (en) 2005-11-24 2006-10-12 Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer

Publications (1)

Publication Number Publication Date
DK1951274T3 true DK1951274T3 (da) 2010-02-01

Family

ID=37654955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06806214.0T DK1951274T3 (da) 2005-11-24 2006-10-12 Parapoxvirusser i kombination med klasssiske cytotoksiske kemoterapeutiske midler som biokemoterapi til behandling af cancer

Country Status (15)

Country Link
US (1) US7897159B2 (da)
EP (1) EP1951274B1 (da)
JP (1) JP5164849B2 (da)
CN (1) CN101312737B (da)
AR (1) AR057922A1 (da)
AT (1) ATE450266T1 (da)
CA (1) CA2630833C (da)
DE (1) DE602006010902D1 (da)
DK (1) DK1951274T3 (da)
ES (1) ES2335308T3 (da)
HK (1) HK1117427A1 (da)
PL (1) PL1951274T3 (da)
PT (1) PT1951274E (da)
TW (1) TWI415617B (da)
WO (1) WO2007059821A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006021142D1 (de) 2005-02-03 2011-05-19 Gen Hospital Corp Verfahren zur behandlung von gefitinib-resistentem krebs
CN103110948A (zh) 2005-11-04 2013-05-22 惠氏公司 mTOR抑制剂、赫赛汀和/或HKI-272的抗肿瘤组合
US8022216B2 (en) 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
DK2656844T3 (da) 2008-06-17 2015-03-02 Wyeth Llc Antineoplastiske kombinationer indeholdende hki-272 og vinorelbin
CN105963313A (zh) 2008-08-04 2016-09-28 惠氏有限责任公司 4-苯胺基-3-氰基喹啉和卡培他滨的抗肿瘤组合
AU2010234968B2 (en) 2009-04-06 2015-05-14 Wyeth Llc Treatment regimen utilizing neratinib for breast cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3816139A1 (de) 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern
DE19922407A1 (de) 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
DE50109630D1 (de) * 2000-07-11 2006-06-01 Bayer Healthcare Ag Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs
AR035227A1 (es) * 2001-02-20 2004-05-05 Oncolytics Biotech Inc Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
NZ512341A (en) * 2001-06-13 2004-02-27 Bayer Ag Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
CN1754002B (zh) * 2002-08-12 2010-09-08 杰能斯有限公司 涉及痘病毒和癌的组合物及制备方法

Also Published As

Publication number Publication date
US7897159B2 (en) 2011-03-01
DE602006010902D1 (de) 2010-01-14
ES2335308T3 (es) 2010-03-24
EP1951274B1 (en) 2009-12-02
HK1117427A1 (en) 2009-01-16
TW200738250A (en) 2007-10-16
PL1951274T3 (pl) 2010-05-31
ATE450266T1 (de) 2009-12-15
CA2630833A1 (en) 2007-05-31
CN101312737A (zh) 2008-11-26
US20090035269A1 (en) 2009-02-05
CA2630833C (en) 2015-01-06
JP2009517347A (ja) 2009-04-30
WO2007059821A1 (en) 2007-05-31
CN101312737B (zh) 2012-11-14
PT1951274E (pt) 2009-12-14
TWI415617B (zh) 2013-11-21
AR057922A1 (es) 2007-12-26
JP5164849B2 (ja) 2013-03-21
EP1951274A1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
DK3567035T3 (da) N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer
CL2007002640A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
DK2155758T3 (da) Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
DE602006019852D1 (de) Verriegelungsspannfutter
CL2008000751A1 (es) Compuestos derivados de cicloprop[d]indolo[2,1-a][2]benzacepina sustituidos con heterociclos; composicion farmaceutica; y uso en el tratamiento de infeccion por hepatitis c.
DK2004183T3 (da) Mazindol-kombination i behandlingen af opmærksomhedsunderskud/hyperaktivitet
BRPI0808043A2 (pt) Compostos tricíclicos úteis no tratamento de distúrbios de ferro.
IL186217A0 (en) Anti-inflammatory modalities
CL2007002951A1 (es) Uso de compuestos derivados de espiroheterociclicos en el tratamiento de hipercolesterolemia, hiperplasia benigna de prostata, pruritis, cancer.
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
DK1709082T3 (da) Sammensætning til behandling af patologi knyttet til MSRV/HERV-W
DK1951274T3 (da) Parapoxvirusser i kombination med klasssiske cytotoksiske kemoterapeutiske midler som biokemoterapi til behandling af cancer
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
DE602006018391D1 (de) Photoresistmonomer, dessen Polymer und diesen enthaltende Fotolackzusammensetzung
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
BRPI0812924A2 (pt) Imunocitocinas para o tratamento de câncer em combinação com agentes quimioterapêuticos
AU312299S (en) Circular saw
FI20055090A0 (fi) Lukitusväline
DK1909800T3 (da) Acylglycerophospholipider til behandling af symptomer i forbindelse med cancer
GB0503775D0 (en) The compound used in the treatment of HIV
ES1059713Y (es) Piezas reforzadas de marmol, granito y similares.